The hyper-growth of Vyalev, with revenue increasing over 100% in the last six months, indicates a highly successful product launch. This rapid scaling creates pressure on manufacturing, supply chain logistics, and sales/marketing operations to support continued market share capture.
Filing excerpt
Net revenues for Vyalev increased greater than 100% for the three and six months ended June 30, 2026 primarily driven by strong market share uptake.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10qproductLaunchGet every 10-Q signal for AbbVie and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AbbVie this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/0c37380e-ac10-4371-9436-1e3034ad0635 returns this record as JSON. POST /v1/companies/enrich returns every signal for abbvie.com.
{
"signal_id": "0c37380e-ac10-4371-9436-1e3034ad0635",
"signal_type": "sec-10q",
"signal_subtype": "productLaunch",
"detected_at": "2026-08-04T07:07:38.097+00:00",
"company": {
"name": "AbbVie",
"domain": "abbvie.com"
},
"data": {
"detail": "The hyper-growth of Vyalev, with revenue increasing over 100% in the last six months, indicates a highly successful product launch. This rapid scaling creates pressure on manufacturing, supply chain logistics, and sales/marketing operations to support continued market share capture.",
"metrics": {
"pct": 1,
"timeframe": "current_quarter",
"pct_context": "Revenue growth for Vyalev (greater than 100%)"
},
"summary": "AbbVie's Vyalev revenue grows over 100% due to strong market share uptake",
"excerpts": "Net revenues for Vyalev increased greater than 100% for the three and six months ended June 30, 2026 primarily driven by strong market share uptake.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115226000026/abbv-20260630.htm",
"filing_date": "2026-08-03",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic"
}
}
curl https://signals.autobound.ai/v1/signals/0c37380e-ac10-4371-9436-1e3034ad0635 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"abbvie.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.